Collaboration, Bias Towards NK Cells, and Optimism for Improving Leukemia Treatment

The 5th International Workshop on CAR-T (iwCAR-T) took place in Scottsdale, AZ, on 14 – 16 April, 2023, and brought together world-leading experts in CAR-T therapy as they discussed the latest in the field. In this podcast series, you will gain an insight into the sessions that took place at this year’s meeting, which covered the latest updates in CAR-T therapy in chronic lymphocytic leukemia (CLL), lymphoma, acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and more.

In this podcast, you will hear from David Sallman, MD, Moffitt Cancer Center, Tampa, FL, Marion Subklewe, MD, Ludwig-Maximilians University, Munich, Germany, and Roman Shapiro, MD, Dana-Farber Cancer Institute, Boston, MA, who discuss major challenges with CAR-T therapy in AML, strategies to improve outcomes for patients, and more.

The post iwCAR-T Session III: CAR-T therapy in AML: ongoing challenges and strategies to improve patient outcomes appeared first on VJHemOnc.